CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
According to a phase 3 study, the omalizumab biosimilar saw comparable results with a good safety profile.
Related Articles
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa
This cross-sectional study examines the association between serum immunoglobulin G levels and underlying nicastrin variation in individuals with hidradenitis suppurativa.
Combining Minoxidil and LLLT Does Not Improve Treatment Outcomes for Androgenic Alopecia
Compared to minoxidil alone, the combination therapy saw no significant differences in hair count and diameter.
Exploring Oral Therapies for Hyperhidrosis: Current and Future Perspectives
Adam Friedman, MD, FAAD, takes a closer look at the emerging landscape of oral treatments for hyperhidrosis and what lies ahead in advancing patient care.
Acne Relapse and Isotretinoin Retrial in Patients With Acne
This cohort study assess rates of acne relapse and isotretinoin retrial and identifies associated factors in patients after completing an isotretinoin course.
Optimizing Hidradenitis Suppurativa Management: From Current Challenges to Emerging Therapies and Future Perspectives
Panelists discuss how hidradenitis suppurativa poses significant diagnostic and treatment challenges, while exploring current management approaches, emerging therapies, dosing considerations, and the potential of AI…
Novel RF and HIFES Device is Effective for Enhancing Facial Laxity Among Asian Patients
Combining synchronized radiofrequency with high intensity facial electrical stimulation led to firmer, smoother, and more lifted skin.
Developing an OTC Dermatology Product
Renata Block, MMS, PA-C, and Erica Ramos, PA-C, discuss the complexities of developing an over-the-counter hair product.
EADV 2024 Interview: Branka Marinović
This is one field of dermatology that, in the last 20 years, developed very rapidly in the field of diagnostic methods, but also in the…
